Montanaro Asset Management Ltd lessened its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 6.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 168,300 shares of the business services provider's stock after selling 11,200 shares during the quarter. Exponent comprises approximately 3.1% of Montanaro Asset Management Ltd's investment portfolio, making the stock its 12th biggest holding. Montanaro Asset Management Ltd owned approximately 0.33% of Exponent worth $14,996,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Private Trust Co. NA lifted its holdings in Exponent by 129.8% in the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock valued at $25,000 after buying an additional 157 shares during the period. Atala Financial Inc acquired a new stake in shares of Exponent during the fourth quarter worth $25,000. Westside Investment Management Inc. acquired a new stake in shares of Exponent in the 3rd quarter valued at about $26,000. Tortoise Investment Management LLC lifted its holdings in shares of Exponent by 76.7% in the fourth quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after purchasing an additional 191 shares in the last quarter. Finally, Trust Co. of Vermont acquired a new position in shares of Exponent during the fourth quarter worth about $45,000. Institutional investors own 92.37% of the company's stock.
Exponent Stock Performance
Exponent stock traded up $0.19 during midday trading on Friday, reaching $82.23. The stock had a trading volume of 289,130 shares, compared to its average volume of 231,863. The stock has a market capitalization of $4.18 billion, a P/E ratio of 38.79 and a beta of 0.77. The firm's fifty day simple moving average is $86.78 and its 200-day simple moving average is $95.69. Exponent, Inc. has a 1-year low of $77.30 and a 1-year high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period in the prior year, the firm earned $0.41 EPS. On average, sell-side analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Insider Transactions at Exponent
In other news, VP Richard Reiss sold 1,736 shares of the company's stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. This represents a 49.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 2.10% of the company's stock.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.